Summit Securities Group’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.44K Buy
16
+4
+33% +$666 ﹤0.01% 1079
2026
Q1
$2.52K Sell
12
-92
-88% -$23.1K ﹤0.01% 917
2025
Q4
$29.6K Sell
104
-17
-14% -$5.32K ﹤0.01% 729
2025
Q3
$37.4K Buy
121
+74
+157% +$23.2K 0.01% 639
2025
Q2
$14.8K Buy
+47
New +$13.6K ﹤0.01% 801
2023
Q3
Sell
-92
Closed -$27K 929
2023
Q2
$27K Sell
92
-43
-32% -$13.1K ﹤0.01% 558
2023
Q1
$43K Buy
+135
New +$40K ﹤0.01% 460

Other funds holding PODD

Summit Securities Group's PODD Position: Q2 2026 in Review

Summit Securities Group increased its Insulet (PODD) stake by 33% in Q2 2026, buying an estimated $666 and bringing the position to 16 shares worth $2.44K. The position accounts for ﹤0.01% of the portfolio, ranked #1079.

Summit Securities Group first reported a position in PODD in Q1 2023 and has held it in 7 quarters since. The position peaked at $43K in Q1 2023. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • Summit Securities Group held 16 shares of Insulet worth $2.44K as of Q2 2026.
  • Summit Securities Group bought 4 Insulet shares in Q2 2026, an estimated $666.
  • Insulet made up ﹤0.01% of Summit Securities Group's portfolio in Q2 2026, its #1079 holding.
  • Summit Securities Group first reported a position in Insulet in Q1 2023 and has held it in 7 quarters since.
  • Summit Securities Group's Insulet position peaked at $43K in Q1 2023.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.